The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures
Identifieur interne : 000695 ( Istex/Checkpoint ); précédent : 000694; suivant : 000696The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures
Auteurs : Erik De Clercq [Belgique]Source :
- Medicinal Research Reviews [ 0198-6325 ] ; 2011-01.
Abstract
This review article presents the fifth part (part E) in the series of stories on antiviral drug discovery. The ten stories belonging to this fifth part are dealing with (i) aurintricarboxylic acid; (ii) alkenyldiarylmethanes; (iii) human immunodeficiency virus (HIV) integrase inhibitors; (iv) lens epithelium‐derived growth factor as a potential target for HIV proviral DNA integration; (v) the status presens of neuraminidase inhibitors NAIs in the control of influenza virus infections; (vi) the status presens on respiratory syncytial virus inhibitors; (vii) tricyclic (1,N‐2‐ethenoguanine)‐based acyclovir and ganciclovir derivatives; (viii) glycopeptide antibiotics as antivirals targeted at viral entry; (ix) the potential (off‐label) use of cidofovir in the treatment of polyoma (JC and BK) virus infections; and (x) finally, thymidine phosphorylase as a target for both antiviral and anticancer agents. © 2009 Wiley Periodicals, Inc. Med Res Rev, 31, No. 1, 118–160, 2010
Url:
DOI: 10.1002/med.20179
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:7746198113E832BD134B595843C78637FB9F9EA7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures</title><author><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7746198113E832BD134B595843C78637FB9F9EA7</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/med.20179</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-9WJKKRQ6-6/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000A98</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000A98</idno><idno type="wicri:Area/Istex/Curation">000A98</idno><idno type="wicri:Area/Istex/Checkpoint">000695</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000695</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures</title><author><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name><affiliation wicri:level="1"><country xml:lang="fr">Belgique</country><wicri:regionArea>Rega Institute for Medical Research, K.U.Leuven, Minderbroedersstraat 10, B‐3000 Leuven</wicri:regionArea><wicri:noRegion>B‐3000 Leuven</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Belgique</country></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Belgique</country><wicri:regionArea>Correspondence address: Rega Institute for Medical Research, K.U.Leuven, Minderbroedersstraat 10, B‐3000 Leuven</wicri:regionArea><wicri:noRegion>B‐3000 Leuven</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Medicinal Research Reviews</title><title level="j" type="alt">MEDICINAL RESEARCH REVIEWS</title><idno type="ISSN">0198-6325</idno><idno type="eISSN">1098-1128</idno><imprint><biblScope unit="vol">31</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="118">118</biblScope><biblScope unit="page" to="160">160</biblScope><biblScope unit="page-count">43</biblScope><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-01">2011-01</date></imprint><idno type="ISSN">0198-6325</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0198-6325</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This review article presents the fifth part (part E) in the series of stories on antiviral drug discovery. The ten stories belonging to this fifth part are dealing with (i) aurintricarboxylic acid; (ii) alkenyldiarylmethanes; (iii) human immunodeficiency virus (HIV) integrase inhibitors; (iv) lens epithelium‐derived growth factor as a potential target for HIV proviral DNA integration; (v) the status presens of neuraminidase inhibitors NAIs in the control of influenza virus infections; (vi) the status presens on respiratory syncytial virus inhibitors; (vii) tricyclic (1,N‐2‐ethenoguanine)‐based acyclovir and ganciclovir derivatives; (viii) glycopeptide antibiotics as antivirals targeted at viral entry; (ix) the potential (off‐label) use of cidofovir in the treatment of polyoma (JC and BK) virus infections; and (x) finally, thymidine phosphorylase as a target for both antiviral and anticancer agents. © 2009 Wiley Periodicals, Inc. Med Res Rev, 31, No. 1, 118–160, 2010</div></front></TEI><affiliations><list><country><li>Belgique</li></country></list><tree><country name="Belgique"><noRegion><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name></noRegion><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000695 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000695 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:7746198113E832BD134B595843C78637FB9F9EA7
|texte= The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures
}}
| This area was generated with Dilib version V0.6.33. |  |